Analyzing NeurAxis (NRXS) and The Competition

NeurAxis (NASDAQ:NRXSGet Free Report) is one of 76 publicly-traded companies in the “Electromedical equipment” industry, but how does it contrast to its peers? We will compare NeurAxis to similar businesses based on the strength of its profitability, institutional ownership, analyst recommendations, valuation, risk, dividends and earnings.


This table compares NeurAxis and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NeurAxis -594.55% N/A -899.27%
NeurAxis Competitors -152.82% -47.30% -5.25%

Insider and Institutional Ownership

11.8% of NeurAxis shares are owned by institutional investors. Comparatively, 45.1% of shares of all “Electromedical equipment” companies are owned by institutional investors. 14.8% of shares of all “Electromedical equipment” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares NeurAxis and its peers gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
NeurAxis $2.46 million -$14.63 million -0.66
NeurAxis Competitors $950.21 million $83.22 million -7.95

NeurAxis’ peers have higher revenue and earnings than NeurAxis. NeurAxis is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for NeurAxis and its peers, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeurAxis 0 0 1 0 3.00
NeurAxis Competitors 240 758 2017 101 2.64

As a group, “Electromedical equipment” companies have a potential upside of 19.07%. Given NeurAxis’ peers higher possible upside, analysts clearly believe NeurAxis has less favorable growth aspects than its peers.


NeurAxis peers beat NeurAxis on 8 of the 12 factors compared.

NeurAxis Company Profile

(Get Free Report)

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Receive News & Ratings for NeurAxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeurAxis and related companies with's FREE daily email newsletter.